Publication: Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response
No Thumbnail Available
Date
2025
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley and Sons Inc
Abstract
[No abstract available]